FDA Seeks To Speed Seizure, Injunction Decisions With More Collaboration
This article was originally published in The Gray Sheet
Executive Summary
FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.